Further, we reported that reducing the human VDAC1 gene in an in vitro condition might enhance synaptic activity, improve mitochondrial maintenance and function, and protect against AD‐related genes' toxicities (Manczak & Reddy, 2013). This evidence concerns the gene VDAC1 and Alzheimer disease.